We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01118832
Recruitment Status : Unknown
Verified May 2010 by Sidney Kimmel Comprehensive Cancer Center.
Recruitment status was:  Recruiting
First Posted : May 7, 2010
Last Update Posted : May 7, 2010
Information provided by:

Study Description
Brief Summary:
A novel infrared imaging tool to aid in the clinical detection of atypical pigmented lesions and melanoma is developed. Goals include evaluation of the utility of high-resolution infrared scanning of cutaneous lesions in the diagnosis of pigmented lesions and the identification of high-risk lesions and melanomas.

Condition or disease

Study Design

Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Case-Only
Official Title: Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Study Start Date : September 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   10 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The subject population will be identified in the Department of Dermatology Pigmented Lesion Clinic at the Johns Hopkins Hospital Outpatient Center. Recruited patients will only comprise those requesting a cutaneous pigmented lesion removed or patients that are examined and found to have a pigmented lesion that is suspicious for malignancy at the time of their visit, and thus recommended to have a skin biopsy for diagnosis following the standard of care

Inclusion Criteria:

  • Patients seen in the high-risk pigmented lesion clinic, who posses a pigmented lesion with a clinical indication for biopsy

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01118832

United States, Maryland
Johns Hopkins Medicine Recruiting
Baltimore, Maryland, United States, 21287
Contact: Rhoda Alani, MD    617-638-5517    ralani@jhmi.edu   
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins University
Boston University
Principal Investigator: Rhoda Alani, MD Johns Hopkins University
More Information

Responsible Party: Rhoda Alani, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01118832     History of Changes
Other Study ID Numbers: J0868
First Posted: May 7, 2010    Key Record Dates
Last Update Posted: May 7, 2010
Last Verified: May 2010

Keywords provided by Sidney Kimmel Comprehensive Cancer Center:

Additional relevant MeSH terms:
Dysplastic Nevus Syndrome
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas
Neoplastic Syndromes, Hereditary
Genetic Diseases, Inborn